Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case...
Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundMonoclonal antibodies targeting the PD-1/PD-L1 axis have gained increasing attention across many solid tumors and hematologic malignancies due to their efficacy and favorable toxicity profile. With more than 1 agent now FDA-approved in a wide variety of tumor types, and with others in clinical trials, it is becoming more common that patie...
Alternative Titles
Full title
Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_08058c80515e480087dd1266ababaf12
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08058c80515e480087dd1266ababaf12
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1186/s40425-017-0273-y
